Evidence map›Paper›PMID 23917313›Full record

ArticleAntimicrobial agents and chemotherapy2013

Characterization of fecal extended-spectrum-β-lactamase-producing Escherichia coli in a remote community during a long time period.

Paul-Louis Woerther, Cécile Angebault, Hervé Jacquier, Olivier Clermont, Assyia El Mniai, Brigitte Moreau, Félix Djossou, Gilles Peroz, François Catzeflis, Erick Denamur and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Extended-Spectrum Beta-Lactamases ProducingInfection and drug resistance · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. SpecificAntimicrobial agents and chemotherapy · 2017
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Paul-Louis WoertherLaboratory of Microbiology, Institut Gustave Roussy, Villejuif, France.
Cécile Angebault
Hervé Jacquier
Olivier Clermont
Assyia El Mniai
Brigitte Moreau
Félix Djossou
Gilles Peroz
François Catzeflis
Erick Denamur
Antoine Andremont
Assistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Andrée Rosemon · GFDélégation Paris 7 · FRSorbonne Paris Cité · FRHôpital Bichat-Claude-Bernard · FRUniversité de Montpellier · FRUniversity of French Guiana · GF

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carriage of extended-spectrum beta-lactamase-producing enterobacteria (ESBL-E) has increased in community settings. Little is known about their long-term evolution. French Guiana Amerindians living in a very remote village, already sampled in 2001 and 2006 for ESBL-E fecal carriage, were screened again in October 2010. Sociodemographic data and antibiotic intake data were collected during the previous year. ESBL-E strains collected in 2010 and their plasmid contents were typed. The results were compared to those of the previous campaigns. The prevalence of ESBL-E carriage in 2010 was 5.3%, whereas it was 8.0% and 3.2% in 2006 and 2001, respectively. As previously determined, no individual factor was associated with carriage, including personal antibiotic exposure. However, overall antibiotic use had decreased to a 0.67 treatments/subject/year in 2010 versus 1.09 in 2006 (P < 0.001), which supports the idea that population exposure to antibiotics impacts on ESBL-E community carriage rates. A wide diversity of ESBL Escherichia coli strains belonging to the A0, A1, B1, and D2 phylogroups and producing the CTX-M-1, CTX-M-2, and CTX-M-8 enzymes were isolated. Despite the overall genetic diversity of the strains evaluated by repetitive extragenic palindromic PCR (rep-PCR) and multilocus sequence typing, two CTX-M-1-producing clones were found to have spread. In contrast, similar ESBL-bearing I1/Iγ plasmids were present in various strains both within and between carriers, suggesting high rates of plasmid transfer. Our results suggest that overall antibiotic exposure affects ESBL-E fecal carriage in the community. ESBL-E spread may be the result of both strain dissemination and the transfer of plasmids in intestinal microbiota.

Indexed as

AdolescentAdultAnti-Bacterial Agentsbeta-LactamasesEscherichia coliEscherichia coli ProteinsFecesFemaleHumansMalePhylogenyRisk FactorsYoung AdultAnti-Bacterial Agentsbeta-lactamase CTX-2beta-Lactamasesbeta-lactamase TEM-3CTX-M-9 protein, E coliEscherichia coli Proteins

Identifiers

PMID23917313
PMCPMC3811437
OpenAlexW2019282161

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.